Found 9 results
Name | Type of Offering | Accepted Date |
---|---|---|
BioAegis Therapeutics, Inc.
See All Filings
|
D | 2012-04-11 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-12-000002
Exclusions or Exemptions
N/A
Accepted Date
2012-04-11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D | 2022-05-11 10:40:57 |
Amount To Be Raised
$21,770,592
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-05-11 10:40:57
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D/A | 2020-10-07 13:52:58 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-10-07 13:52:58
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D/A | 2013-02-07 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-13-000001
Exclusions or Exemptions
N/A
Accepted Date
2013-02-07
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D/A | 2015-04-17 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-15-000001
Exclusions or Exemptions
506b
Accepted Date
2015-04-17
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D/A | 2014-02-07 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-14-000001
Exclusions or Exemptions
506b
Accepted Date
2014-02-07
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D | 2016-03-11 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-16-000002
Exclusions or Exemptions
506b
Accepted Date
2016-03-11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D | 2018-09-26 15:21:12 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-18-000003
Exclusions or Exemptions
506b
Accepted Date
2018-09-26 15:21:12
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
BioAegis Therapeutics, Inc.
See All Filings
|
D | 2020-06-17 15:10:31 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001546604
Filed Document
0001546604-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-06-17 15:10:31
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|